The authors found that BNC2 transcriptional induction is a specific feature of in vivo myofibroblastic activation in liver fibrosis, extended to lung or heart injury, indicating BNC2 as a marker of myofibroflasts across different organs. This evidence concerns the gene BNC2 and Hepatic fibrosis.